DLX4
DLX4 is a gene that encodes a member of the Distal-less (Dlx) gene family. The Dlx gene family is involved in embryonic development and primarily regulates the formation of craniofacial structures. The DLX4 gene is located on chromosome 17 in humans and is expressed in a variety of tissues, including the placenta and bone marrow.
Function[edit]
The DLX4 gene is a homeobox gene, which means it encodes a protein that binds to specific DNA sequences and regulates the activity of other genes. The protein encoded by the DLX4 gene is a transcription factor, which means it helps control the process of converting, or transcribing, DNA into RNA.
In particular, the DLX4 protein is thought to play a role in the development of the placenta during pregnancy. It may also be involved in the regulation of hematopoiesis, the process by which the body produces new blood cells.
Clinical Significance[edit]
Alterations in the DLX4 gene have been associated with a variety of health conditions. For example, overexpression of DLX4 has been observed in several types of cancer, including breast cancer and ovarian cancer. This overexpression may contribute to the growth and spread of cancer cells.
In addition, mutations in the DLX4 gene have been linked to pre-eclampsia, a potentially serious condition that can occur during pregnancy. Pre-eclampsia is characterized by high blood pressure and damage to organs such as the liver and kidneys.
Research[edit]
Research into the DLX4 gene and its associated protein is ongoing. Scientists are particularly interested in understanding how alterations in the DLX4 gene contribute to the development of cancer and other diseases. This research could potentially lead to new treatments for these conditions.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian